Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,028 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed Ina CTivated infl Uenza vaccine in adult S aged 65 years and above (INVICTUS): a study protocol.
Swayze H, Allen J, Folegatti P, Yu LM, Gilbert S, Hill A, Ellis C, Butler CC. Swayze H, et al. Among authors: ellis c. F1000Res. 2019 May 23;8:719. doi: 10.12688/f1000research.19090.1. eCollection 2019. F1000Res. 2019. PMID: 32089822 Free PMC article. Clinical Trial.
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line.
Folegatti PM, Bellamy D, Flaxman A, Mair C, Ellis C, Ramon RL, Ramos Lopez F, Mitton C, Baker M, Poulton I, Lawrie A, Roberts R, Minassian A, Ewer KJ, Evans TG, Hill AVS, Gilbert SC. Folegatti PM, et al. Among authors: ellis c. Vaccines (Basel). 2019 Mar 22;7(1):33. doi: 10.3390/vaccines7010033. Vaccines (Basel). 2019. PMID: 30909516 Free PMC article.
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS).
Butler C, Ellis C, Folegatti PM, Swayze H, Allen J, Bussey L, Bellamy D, Lawrie A, Eagling-Vose E, Yu LM, Shanyinde M, Mair C, Flaxman A, Ewer K, Gilbert S, Evans TG, On Behalf Of The Invictus Investigators. Butler C, et al. Among authors: ellis c. Vaccines (Basel). 2021 Aug 3;9(8):851. doi: 10.3390/vaccines9080851. Vaccines (Basel). 2021. PMID: 34451976 Free PMC article.
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
Evans TG, Bussey L, Eagling-Vose E, Rutkowski K, Ellis C, Argent C, Griffin P, Kim J, Thackwray S, Shakib S, Doughty J, Gillies J, Wu J, Druce J, Pryor M, Gilbert S. Evans TG, et al. Among authors: ellis c. Lancet Infect Dis. 2022 Jun;22(6):857-866. doi: 10.1016/S1473-3099(21)00702-7. Epub 2022 Mar 16. Lancet Infect Dis. 2022. PMID: 35305317 Clinical Trial.
Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study.
Evans TG, Castellino F, Kowalik Dobczyk M, Tucker G, Walley AM, Van Leuven K, Klein J, Rutkowski K, Ellis C, Eagling-Vose E, Treanor J, van Baalen C, Filkov E, Laurent C, Thacker J, Asher J, Donabedian A. Evans TG, et al. Among authors: ellis c. Lancet Microbe. 2024 May 7:S2666-5247(24)00024-7. doi: 10.1016/S2666-5247(24)00024-7. Online ahead of print. Lancet Microbe. 2024. PMID: 38729196 Free article.
A contact binary satellite of the asteroid (152830) Dinkinesh.
Levison HF, Marchi S, Noll KS, Spencer JR, Statler TS, Bell JF 3rd, Bierhaus EB, Binzel R, Bottke WF, Britt D, Brown ME, Buie MW, Christensen PR, Dello Russo N, Emery JP, Grundy WM, Hahn M, Hamilton VE, Howett C, Kaplan H, Kretke K, Lauer TR, Manzoni C, Marschall R, Martin AC, May BH, Mottola S, Olkin CB, Pätzold M, Parker JW, Porter S, Preusker F, Protopapa S, Reuter DC, Robbins SJ, Salmon J, Simon AA, Stern SA, Sunshine JM, Wong I, Weaver HA, Adam C, Ancheta S, Andrews J, Anwar S, Barnouin OS, Beasley M, Berry KE, Birath E, Bolin B, Booco M, Burns R, Campbell P, Carpenter R, Crombie K, Effertz M, Eifert E, Ellis C, Faiks P, Fischetti J, Fleming P, Francis K, Franco R, Freund S, Gallagher C, Geeraert J, Gobat C, Gorgas D, Granat C, Gray S, Haas P, Harch A, Hegedus K, Isabelle C, Jackson B, Jacob T, Jennings S, Kaufmann D, Keeney BA, Kennedy T, Lauffer K, Lessac-Chenen E, Leonard R, Levine A, Lunsford A, Martin T, McAdams J, Mehall G, Merkley T, Miller G, Montanaro M, Montgomery A, Murphy G, Myers M, Nelson DS, Ocampo A, Olds R, Pelgrift JY, Perkins T, Pineau J, Poland D, Ramanan V, Rose D, Sahr E, Short O, Solanki I, Stanbridge D, Sutter B, Talpas Z, Taylor H, Treiu B, Ver… See abstract for full author list ➔ Levison HF, et al. Among authors: ellis c. Nature. 2024 May;629(8014):1015-1020. doi: 10.1038/s41586-024-07378-0. Epub 2024 May 29. Nature. 2024. PMID: 38811709 Free PMC article.
Generalisation of Social Communication Skills by Autistic Children During Play-Based Assessments Across Home, School and an Unfamiliar Research Setting.
Carruthers S, Charman T, Leadbitter K, Ellis C, Taylor L, Moore H, Taylor C, James K, Balabanovska M, Langhorne S, Aldred C, Slonims V, Grahame V, Howlin P, McConachie H, Parr J, Emsley R, Le Couteur A, Green J, Pickles A; and the PACT-G Trial Group. Carruthers S, et al. Among authors: ellis c. J Autism Dev Disord. 2024 May 14. doi: 10.1007/s10803-024-06370-x. Online ahead of print. J Autism Dev Disord. 2024. PMID: 38743153
Dermoscopy can be safely and reliably used in ophthalmology.
Schneider KJ, Flaharty KG, Ellis CN, Bitar OM, Barinova H, Tejasvi T, Nelson CC. Schneider KJ, et al. Among authors: ellis cn. Heliyon. 2024 Apr 28;10(9):e30293. doi: 10.1016/j.heliyon.2024.e30293. eCollection 2024 May 15. Heliyon. 2024. PMID: 38737239 Free PMC article.
2,028 results